These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. Kumar P; Kumar A J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208 [TBL] [Abstract][Full Text] [Related]
4. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Galpern WR; Matthews RT; Beal MF; Isacson O Neuroreport; 1996 Nov; 7(15-17):2639-42. PubMed ID: 8981438 [TBL] [Abstract][Full Text] [Related]
9. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats. Ramachandran S; Thangarajan S Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats. Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362 [TBL] [Abstract][Full Text] [Related]
11. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro. Colle D; Hartwig JM; Soares FA; Farina M Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028 [TBL] [Abstract][Full Text] [Related]
12. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum. Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139 [TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Massieu L; Del Río P; Montiel T Neuroscience; 2001; 106(4):669-77. PubMed ID: 11682154 [TBL] [Abstract][Full Text] [Related]
14. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease. Ryu JK; Kim SU; McLarnon JG Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Schulz JB; Matthews RT; Henshaw DR; Beal MF Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553 [TBL] [Abstract][Full Text] [Related]
18. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Klivenyi P; Andreassen OA; Ferrante RJ; Dedeoglu A; Mueller G; Lancelot E; Bogdanov M; Andersen JK; Jiang D; Beal MF J Neurosci; 2000 Jan; 20(1):1-7. PubMed ID: 10627575 [TBL] [Abstract][Full Text] [Related]
19. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase. Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872 [TBL] [Abstract][Full Text] [Related]
20. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway. Jamwal S; Kumar P Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]